{"id":"https://openalex.org/W4281786876","doi":"https://doi.org/10.2337/db22-1406-p","title":"1406-P: ZP8396, a Novel Amylin Analogue, Induces Weight Loss in DIO Rats with a Formulation Space at Physiological pH","display_name":"1406-P: ZP8396, a Novel Amylin Analogue, Induces Weight Loss in DIO Rats with a Formulation Space at Physiological pH","publication_year":2022,"publication_date":"2022-05-31","ids":{"openalex":"https://openalex.org/W4281786876","doi":"https://doi.org/10.2337/db22-1406-p"},"language":"en","primary_location":{"id":"doi:10.2337/db22-1406-p","doi":"https://doi.org/10.2337/db22-1406-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db22-1406-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014807421","display_name":"Jolanta Skarbaliene","orcid":"https://orcid.org/0000-0003-3965-7504","observed_orcids":["https://orcid.org/0000-0003-3965-7504"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JOLANTA SKARBALIENE","raw_affiliation_strings":["S\u00f8borg, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S\u00f8borg, Copenhagen, Denmark","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077086226","display_name":"JOAKIM LUNDQVIST","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JOAKIM LUNDQVIST","raw_affiliation_strings":["S\u00f8borg, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S\u00f8borg, Copenhagen, Denmark","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022088135","display_name":"Jesper Skodborg Villadsen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JESPER VILLADSEN","raw_affiliation_strings":["S\u00f8borg, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S\u00f8borg, Copenhagen, Denmark","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1245,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.31807895,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"71","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10489","display_name":"Regulation of Appetite and Obesity","score":0.5565999746322632,"subfield":{"id":"https://openalex.org/subfields/2807","display_name":"Endocrine and Autonomic Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10489","display_name":"Regulation of Appetite and Obesity","score":0.5565999746322632,"subfield":{"id":"https://openalex.org/subfields/2807","display_name":"Endocrine and Autonomic Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.30790001153945923,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.08900000154972076,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/amylin-analogues","display_name":"amylin analogues","score":0.996999979019165},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.8569999933242798},{"id":"https://openalex.org/keywords/diet-induced-obesity","display_name":"diet-induced obesity","score":0.9679999947547913},{"id":"https://openalex.org/keywords/aqueous-formulation","display_name":"aqueous formulation","score":0.48399999737739563},{"id":"https://openalex.org/keywords/physiological-ph","display_name":"physiological pH","score":0.6570000052452087},{"id":"https://openalex.org/keywords/peptide-stability","display_name":"peptide stability","score":0.8199999928474426},{"id":"https://openalex.org/keywords/peptide-aggregation","display_name":"peptide aggregation","score":0.7850000262260437},{"id":"https://openalex.org/keywords/co-formulation","display_name":"co-formulation","score":0.8489999771118164},{"id":"https://openalex.org/keywords/peptide-pharmacology","display_name":"peptide pharmacology","score":0.33399999141693115}],"concepts":[{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.6238914728164673},{"id":"https://openalex.org/C2780705028","wikidata":"https://www.wikidata.org/wiki/Q424643","display_name":"Amylin","level":4,"score":0.5590876340866089},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5445256233215332},{"id":"https://openalex.org/C77056095","wikidata":"https://www.wikidata.org/wiki/Q543183","display_name":"Isotonic","level":2,"score":0.5338692665100098},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4942519962787628},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49169450998306274},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4601614475250244},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4563601016998291},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3517095744609833},{"id":"https://openalex.org/C140793950","wikidata":"https://www.wikidata.org/wiki/Q168091","display_name":"Animal science","level":1,"score":0.3455694615840912},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3312462866306305},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.25329041481018066},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.1868463158607483},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17944416403770447},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.13367927074432373},{"id":"https://openalex.org/C165220095","wikidata":"https://www.wikidata.org/wiki/Q207524","display_name":"Islet","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2337/db22-1406-p","doi":"https://doi.org/10.2337/db22-1406-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db22-1406-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4381378349","https://openalex.org/W4281789620","https://openalex.org/W4399689503","https://openalex.org/W7163635109","https://openalex.org/W7163651702","https://openalex.org/W7163692839","https://openalex.org/W4411292445","https://openalex.org/W3158815391","https://openalex.org/W4411289751","https://openalex.org/W4411294383"],"abstract_inverted_index":{"ZP8396,":[0,95],"currently":[1],"in":[2,59,90,105,148,180],"phase":[3],"1,":[4],"is":[5,103,118,219],"a":[6,46,144],"long-acting,":[7],"amylin":[8],"analogue":[9],"designed":[10],"to":[11,85],"improve":[12],"solubility":[13],"and":[14,16,31,62,75,112,125,151,168,182,185],"stability":[15],"allow":[17],"for":[18,64,82,130,187,197,202,216],"co-formulation":[19,198,210],"with":[20,120,199,213],"other":[21,200],"peptides":[22,201,215],"at":[23,96,109,140,191],"physiological":[24,122,141],"pH.":[25],"Here":[26],"we":[27],"present":[28],"in-vivo":[29],"efficacy":[30],"formulation":[32,108,190],"design":[33],"space":[34],"of":[35,50,71,138,165,209,211],"ZP8396.":[36],"The":[37,69],"acute":[38],"effects":[39],"on":[40],"body":[41],"weight":[42,217],"(BW)":[43],"loss":[44,147,160,179],"after":[45,67],"single":[47],"s.c.":[48],"injection":[49],"ZP8396":[51,72,117,139,175,212],"(0,5,":[52],"3,":[53,74],"30,":[54],"300":[55],"nmol/kg)":[56],"were":[57],"measured":[58],"lean":[60,150,181],"rats":[61,153,184],"monitored":[63],"96":[65],"hours":[66],"dosing.":[68],"ability":[70],"(1,":[73],"15":[76],"nmol/kg,":[77],"s.c.,":[78],"every":[79],"2nd":[80],"day":[81],"21":[83],"days)":[84],"reduce":[86],"BW":[87,146,159,178,204],"was":[88,161],"tested":[89],"diet-induced":[91],"obese":[92],"(DIO)":[93],"rats.":[94],"concentration":[97],"supporting":[98],"pharmacological":[99],"relevant":[100],"human":[101],"doses,":[102],"stable":[104,189],"an":[106],"aqueous":[107,188],"neutral":[110,192],"pH":[111,142,193],"shows":[113],"no":[114],"aggregation":[115],"potential.":[116],"compatible":[119],"different":[121,214],"buffer":[123],"systems":[124],"isotonic":[126],"agents,":[127],"commonly":[128],"used":[129],"commercial":[131],"medicinal":[132],"products":[133],"(Table":[134],"1)":[135],".":[136],"Formulation":[137],"induces":[143,177],"significant":[145,158],"both":[149],"DIO":[152,183],"vs.":[154],"vehicle":[155],"group.":[156],"A":[157],"observed":[162],"from":[163],"start":[164],"the":[166,170],"dosing":[167],"throughout":[169],"study":[171],"period.":[172],"In":[173],"conclusion,":[174],"potently":[176],"allows":[186],"which":[194],"provides":[195],"opportunities":[196],"optimal":[203],"loss.":[205],"Further":[206],"preclinical":[207],"characterization":[208],"management":[218],"ongoing.":[220],"Disclosure":[221],"J.Skarbaliene:":[222],"Employee;":[223,232,237],"Zealand":[224,228,233,238],"Pharma":[225,229,234,239],"A/S,":[226],"Stock/Shareholder;":[227],"A/S.":[230,235,240],"J.Lundqvist:":[231],"J.Villadsen:":[236]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-06-13T00:00:00"}